*Names without addresses are affiliated
facilities
This page does NOT
contain the application for licensure as a
wholesaler.
Click here
if you are not currently registered. You
MUST request a new application before
needing the information on this page.
This page
contains
information
specific to
pharmaceutical
wholesalers and
Nevada's new
Electronic
Pedigree Program
(EPP). Any
questions
regarding
Nevada's
pharmaceutical
wholesaling laws
or the EPP can
be directed to
Carolyn Cramer,
General Counsel at
(775) 850-1440
or at
ccramer@pharmacy.nv.gov.
The following is
a blank Excel
spreadsheet that
can be used by a
wholesaler who
must manually
input pedigree
data or into
which a
wholesaler can
place data it
may already have
so that the data
can be
transmitted to
the EPP in the
proper format.
AB128
Certification of
Completion of
Annual Audit
Monitoring
Compliance With
Code of Conduct
For
Manufacturers
and Wholesalers
of Drugs,
Medicines,
Chemicals,
Devices, or
Appliances (pdf)
(Word)
AB128, Statutes
of Nevada,
Chapter 409
(effective
October 1, 2007)
requires that
all wholesalers
or manufacturers
who employ a
person to sell
or market a
drug, medicine,
chemical,
device, or
appliance in
Nevada comply
with certain
requirements
regarding their
marketing
practices.
Under Nevada
law, NRS
639.007, the
definition of
“drug” and
“medicine”
includes both
prescription
drugs and OTC
medicines and
therefore
manufacturers
and wholesalers
of both
prescription
drugs and OTC
medicines are
required to
comply with AB
128 if they sell
or market a
drug, medicine,
chemical, device
or appliance in
Nevada.
Wholesalers or
Manufacturers of
food, aspirin
and effervescent
saline
analgesics are
exempt from the
AB128. (NRS
639.007(3).
AB128 requires
that each year a
manufacturer or
wholesaler
certify that an
annual audit to
monitor
compliance with
the manufacturer
or wholesaler’s
marketing code
of conduct has
been done. The
certification
forms will be
available on the
Board’s website,
and it is the
manufacturer or
wholesaler’s
responsibility
to download,
complete, and
mail in the form
by June 1 of
every year
starting June 1,
2009.
If a wholesaler
has submitted to
the Board the
information
required
pursuant to
section 5 of
this regulation
at least once,
the wholesaler
may subsequently
submit to the
Board, on a form
provided by the
Board, the
information that
has remained the
same and the
information that
has changed from
the date of the
previous
submission, in
lieu of
submitting the
information
required
annually
pursuant to
section 5 of
this regulation.
If a medical
products
wholesaler has
submitted to the
Board the
information
required
pursuant to
section 8 of
this regulation
at least once,
the medical
products
wholesaler may
subsequently
submit to the
Board, on a form
provided by the
Board, the
information that
has remained the
same and the
information that
has changed from
the date of the
previous
submission, in
lieu of
submitting the
information
required
annually
pursuant to
section 8 of
this regulation.
If a
manufacturer has
submitted to the
Board the
information
required
pursuant to
section 11 or 12
of this
regulation at
least once, the
manufacturer may
subsequently
submit to the
Board, on a form
provided by the
Board, the
information that
has remained the
same and the
information that
has changed from
the date of the
previous
submission, in
lieu of
submitting the
information
required
annually
pursuant to
section 11 or 12
of this
regulation, as
applicable.
The annual
submission of
information to
the Board may be
made by:
(a) Mail or
personal
delivery of a
printed copy of
the information
required;
(b) Electronic
mail to the
Board at the
electronic mail
address
rseidlinger@pharmacy.nv.gov;
or
(c) Such other
technological
means as the
Board may
develop,
including,
without
limitation,
through the use
of the Internet
website of the
Board.
You should
indicate on
each
document
attached to
the form the
number of
the item for
which the
document is
being
submitted.
Please
clearly
indicate on
any document
submitted
with the
form any
claim that
the document
is
confidential
or
proprietary
business
information
subject to
the
disclosure
protections
of Section
1,
subsection
4(d) of AB
128.
If you have
any
questions
please
e-mail Ray
Seidlinger
at
rseidlinger@pharmacy.nv.gov
and allow 10
business
days for a
response.
You
are important to us and we want to be able to communicate
better & faster!
